Edition:
India

Mediclinic International PLC (MDCM.L)

MDCM.L on London Stock Exchange

602.50GBp
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
602.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,855,226
52-wk High
890.18
52-wk Low
495.40

Latest Key Developments (Source: Significant Developments)

Mediclinic International appoints Carel Aron Van Der Merwe as CEO designate​
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Mediclinic International Plc ::‍ANNOUNCES APPOINTMENT OF CAREL ARON VAN DER MERWE, CURRENTLY GROUP CHIEF CLINICAL OFFICER, AS CHIEF EXECUTIVE OFFICER DESIGNATE​.MERWE ‍TO SUCCEED DANIE MEINTJES AS CEO OF COMPANY ON A DATE TO BE MUTUALLY AGREED, BUT NOT LATER THAN 1 AUGUST 2018​.  Full Article

Mediclinic International says H1 2018 ‍underlying EPS down 12 pct to 11.3 pence​
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - MEDICLINIC INTERNATIONAL PLC ::H1 2018 ‍UNDERLYING EARNINGS PER SHARE DOWN 12% TO 11.3 PENCE​.‍H1 REVENUE UP 10% TO GBP1 405M; FLAT IN CONSTANT CURRENCY TERMS​.‍H1 UNDERLYING EBITDA UP 5% TO GBP232M; DECREASED BY 5% IN CONSTANT CURRENCY TERMS​.‍INTERIM DIVIDEND MAINTAINED AT 3.20 PENCE PER SHARE​.SEES MODEST REVENUE GROWTH IN ‍HIRSLANDEN FOR H2​.‍FOR SOUTHERN AFRICA GROUP EXPECTS REVENUE GROWTH TO BE AROUND 4%​ IN H2.‍SEES MARGINAL IMPROVEMENT IN MIDDLE EAST REVENUES FOR FULL YEAR, GRADUAL IMPROVEMENT IN UNDERLYING EBITDA MARGINS OVER TIME,​.‍HAD A GOOD START TO SECOND HALF OF FINANCIAL YEAR, WITH CURRENT TRADING ACROSS ALL OPERATING DIVISIONS IN LINE WITH EXPECTATIONS​.‍GUIDANCE FOR ALL OPERATING DIVISIONS REMAINS UNCHANGED WITH CURRENT 2H18 TRADING IN LINE WITH MANAGEMENT​.  Full Article

Mediclinic confirms approach to Spire; says considering position
Monday, 23 Oct 2017 

Oct 23 (Reuters) - Mediclinic International Plc ::MEDICLINIC INTNL PLC - STATEMENT RE POSSIBLE OFFER.MEDICLINIC INTERNATIONAL PLC - ‍ANNOUNCEMENT REGARDING SPIRE HEALTHCARE GROUP PLC​.‍MEDICLINIC NOTES ANNOUNCEMENT MADE BY SPIRE HEALTHCARE GROUP PLC ("SPIRE") EARLIER TODAY​.MEDICLINIC - ‍CONFIRMS THAT IT MADE AN APPROACH TO SPIRE REGARDING A POSSIBLE OFFER FOR ENTIRE ISSUED AND TO BE ISSUED SHARE CAPITAL OF SPIRE​.‍PROPOSAL WAS REJECTED BY INDEPENDENT DIRECTORS OF SPIRE. AS A CONSEQUENCE, MEDICLINIC IS CONSIDERING ITS POSITION​.  Full Article

UK's Spire says rejects bid from Mediclinic Intl
Monday, 23 Oct 2017 

Oct 23 (Reuters) - Spire Healthcare Group Plc ::SPIRE HEALTHCARE GRP - RESPONSE TO PRESS SPECULATION.SPIRE HEALTHCARE - ‍RECEIVED PRELIMINARY AND CONDITIONAL PROPOSAL FROM MEDICLINIC INTERNATIONAL PLC.SPIRE HEALTHCARE - ‍RECEIVED PROPOSAL TO ACQUIRE ALL OF ISSUED AND TO BE ISSUED SHARES OF SPIRE WHICH MEDICLINIC DOES NOT ALREADY OWN​.‍PROPOSAL COMPRISED 150 PENCE IN CASH AND 0.232 NEW MEDICLINIC SHARES PER SPIRE SHARE​.‍PROPOSAL VALUED EACH SPIRE SHARE AT 298.6 PENCE PER SHARE​.BOARD ‍UNANIMOUSLY REJECTED OFFER ON BASIS THAT IT SIGNIFICANTLY UNDERVALUES SPIRE AND ITS PROSPECTS​.‍SHAREHOLDERS ARE STRONGLY ADVISED TO TAKE NO ACTION IN RELATION TO PROPOSAL​.‍THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE OR AS TO TERMS ON WHICH ANY OFFER MIGHT BE MADE​.  Full Article

Mediclinic International says H1 revenue up 9.5 pct at GBP1.4 billion
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Mediclinic International Plc :‍2017/18 INTERIM TRADING UPDATE​.‍1H18 REVENUE WAS UP 9.5% AT GBP1.4BN (1H17: GBP1.3BN) ​.H1 UNDERLYING EBITDA WAS UP 5.0% AT GBP231M (1H17: GBP220M)​.H1 ‍UNDERLYING EARNINGS PER SHARE IS EXPECTED TO BE AROUND 11.5 PENCE (1H17: 12.8 PENCE)​.TEAMS IN SOUTH AFRICA , SWITERLAND IMPLEMENTED COST SAVINGS PROGRAMMES, PRODUCTIVITY INITIATIVES TO HELP MARGINS DURING H2‍​.‍NEW FACILITIES WILL REDUCE COST OF DEBT ON A LIKE FOR LIKE BASIS BY 25BPS AND EXTEND MATURITY PROFILE TO AT LEAST 2023​.  Full Article

Mediclinic implements cost savings programmes in S. Africa, Switzerland
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Mediclinic International Plc ::FY MARGIN EXPECTATIONS FOR SOUTH AFRICAN BUSINESS (NOT FOR COMPANY) REMAIN IN LINE WITH PREVIOUS GUIDANCE, BROADLY STABLE ON PRIOR YEAR, AT AROUND 21%​.TEAMS IN SOUTH AFRICA, SWITZERLAND IMPLEMENTED COST SAVINGS PROGRAMMES, PRODUCTIVITY INITIATIVES TO HELP MARGINS DURING H2.  Full Article

Mediclinic International says trading in-line with expectations
Tuesday, 27 Sep 2016 

Mediclinic International Plc : Trading is in line with management's expectations . Total revenue for first five months of year was R6,054m in Mediclinic southern africa . Pre-Close trading update for five months ended 31 august 2016 . Underlying EBITDA margins for H1FY17 are expected to be marginally lower than prior year comparator (H1FY16: 21.6%) .Full year 2016/17 guidance remains unchanged across mediclinic's three platforms.  Full Article

Mediclinic says completes refinancing of bridge facility
Tuesday, 28 Jun 2016 

Mediclinic International Plc : Completion of refinancing of bridge facility associated with co's combination with al noor hospitals group plc . New south african senior bank loan totalling zar1.2 billion . New south african unsecured preference share funding totalling zar1.5 billion . New united arab emirates bank loans of $54.5 million and $100.0 million .Remainder of £266 million drawn down from bridge facility satisfied by a $64.5 million payment from existing cash.  Full Article

Mediclinic International FY revenue rises
Wednesday, 25 May 2016 

Mediclinic International Plc : FY revenue 2.11 billion stg versus 1.98 billion stg . FY underlying basic earnings per share increased by 3 pct to 36.7 pence .Proposed final dividend per ordinary share of 5.24 pence.  Full Article

Mediclinic International appoints Myburgh as CFO
Wednesday, 11 May 2016 

Mediclinic International Plc : Appointment of group chief financial officer . Jurgens Myburgh has been appointed as executive director and group chief financial officer . He will join company effective 1 august 2016 .Follows announcement on 23 february 2016 that Craig Tingle will seek early retirement as cfo from 15 june 2016.  Full Article

BRIEF-Mediclinic International appoints Carel Aron Van Der Merwe as CEO designate​

* ‍ANNOUNCES APPOINTMENT OF CAREL ARON VAN DER MERWE, CURRENTLY GROUP CHIEF CLINICAL OFFICER, AS CHIEF EXECUTIVE OFFICER DESIGNATE​